KPTI earnings call for the period ending March 31, 2020.
News & Analysis: Karyopharm Therapeutics
This company's repurposed cancer drug might help patients with severe COVID-19.
These two underrated biotech stocks have the potential to soar.
This cancer-drug maker has a novel medicine with the possibility for extraordinary growth.
KPTI earnings call for the period ending December 31, 2019.
Risk-taking investors flock to biotech for its constant flow of events that can spike or crush the stock prices of the companies developing the latest therapies.
Early next year, Karyopharm expects to unveil pivotal clinical trial results that could send shares soaring.
KPTI earnings call for the period ending September 30, 2019.
KPTI earnings call for the period ending June 30, 2019.
Shares jump after the biopharma receives some praise from Wall Street.